Saturday, October 24, 2026RSS
Peptide.Wire

The daily wire on therapeutic peptides. Regulatory, research, compounding and the incretin race, condensed.

Researchbpc-157safetysystematic review

Systematic review finds only 30 humans studied for BPC-157 safety

The review underscores how thin the clinical evidence base remains for one of the most widely sold gray-market repair peptides.

PR
By Priya Raman · Science Reporter
Oct 21 08:05 ETSource: Dr. Axe

The wire

  1. 01A systematic review reported that human safety data for BPC-157 rest on roughly 30 study participants in total.
  2. 02Clinicians and pharmacists fielding BPC-157 requests have almost no controlled human safety evidence to cite, despite heavy consumer demand and online sales.
  3. 03The underlying publication details, doses and endpoints are not described in this account, so readers should check the primary review before relying on the figure.

From the source

Systematic Review Finds Only 30 Humans Studied For BPC-157 Safety

Read at draxe.com
PeptiPrescribed peptides from $99/moSee all →